NBIX- Neurocrine Biosciences, Inc.

Insider activity in NBIX over the last quarter tilts toward selling: insiders offloaded a net 6,541 shares worth roughly $1.1M.

Classified under Pharmaceuticals (Health Care sector), NBIX's insider flows are most useful compared with peers in the same group.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Gorman Kevin Charles	517.8K	$80.89M	-
CEO	Gano Kyle	154.7K	$24.17M	-
Other	Benevich Eric	67.3K	$10.51M	-
Other	Lippoldt Darin	56.8K	$8.87M	-
CFO	Abernethy Matt	42.8K	$6.73M	-

Buys and sells only

10 filings · page 20

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Nov 30, 2022	Benevich Eric62	Chief Commercial Officer	Sale+OE	50,000	$125.90	$6,295,085.00	-76.2%	-18.9%	-8.2%
Nov 29, 2022	Onyia Jude51	Chief Scientific Officer	Sell	2,331	$121.90	$284,160.09	-49.6%	-16.1%	-6.7%
Nov 10, 2022	Benevich Eric62	Chief Commercial Officer	Sale+OE	24,693	$125.33	$3,094,855.59	-61.2%	-15.2%	-13.0%
Nov 8, 2022	Cooke Julie59	Chief Human Resources Officer	Sale+OE	5,592	$124.99	$698,949.11	-27.0%	-15.2%	-6.9%
Nov 8, 2022	Lippoldt Darin60	Chief Legal Officer	Sale+OE	5,082	$125.04	$635,441.59	-14.8%	-15.2%	-6.9%
Nov 3, 2022	Lippoldt Darin60	Chief Legal Officer	Sale+OE	4,518	$125.02	$564,851.20	-13.4%	-11.2%	-9.4%
Nov 3, 2022	Cooke Julie59	Chief Human Resources Officer	Sale+OE	8,408	$125.00	$1,050,996.96	-35.8%	-11.2%	-9.4%
Nov 3, 2022	Benevich Eric62	Chief Commercial Officer	Sale+OE	9,368	$125.02	$1,171,182.95	-37.5%	-11.2%	-9.4%
Nov 2, 2022	Lippoldt Darin60	Chief Legal Officer	Sale+OE	10,400	$120.28	$1,250,899.00	-26.2%	-9.1%	-7.1%
Oct 31, 2022	Boyer David W.51	Chief Corp. Affairs Officer	Sell	1,295	$114.12	$147,785.40	-30.7%	-5.9%	-3.6%